Cited by 154Gastrointestinal motility and disordersInfant Health and DevelopmentGut microbiota and health

The DOI matches its Crossref record; 141 of the 142 references it cites were found in a registry or an index.

Behavioral and Diet Therapies in Integrated Care for Patients With Irritable Bowel Syndrome

Chey, William D., Keefer, Laurie, Whelan, Kevin, Gibson, Peter R.·2021·Gastroenterology

DOI 10.1053/j.gastro.2020.06.099

Open this paper in CoChat — free account

Abstract

Irritable bowel syndrome (IBS) is a common, symptom-based condition that has negative effects on quality of life and costs health care systems billions of dollars each year. Until recently, management of IBS has focused on over-the-counter and prescription medications that reduce symptoms in fewer than one-half of patients. Patients have increasingly sought natural solutions for their IBS symptoms. However, behavioral techniques and dietary modifications can be effective in treatment of IBS. Behavioral interventions include gastrointestinal-focused cognitive behavioral therapy and gut-directed hypnotherapy to modify interactions between the gut and the brain. In this pathway, benign sensations from the gut induce maladaptive cognitive or affective processes that amplify symptom perception. Symptoms occur in response to cognitive and affective factors that trigger fear of symptoms or lack of acceptance of disease, or from stressors in the external environment. Among the many dietary interventions used to treat patients with IBS, a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols is the most commonly recommended by health care providers and has the most evidence for efficacy. Patient with IBS who choose to follow a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols should be aware of its 3 phases: restriction, reintroduction, and personalization. Management of IBS should include an integrated care model in which behavioral interventions, dietary modification, and medications are considered as equal partners. This approach offers the greatest likelihood for success in management of patients with IBS.

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2020.06.099

Cites

141 of 141 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Bowel Disorders
Lacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866
Self-citation
Collaborative Management of Chronic Illness
Von Korff, M., Gruman, J., Schaefer, J., Curry, S. J., & Wagner, E. H. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-12-199712150-00008 · Cited by 1,269
Thought suppression
Wenzlaff, R. M., & Wegner, D. M. (2000) · Annual Review of Psychology · doi:10.1146/annurev.psych.51.1.59 · Cited by 1,063
Irritable bowel syndrome: a clinical review.
Chey, W., Kurlander, J. E., & Eswaran, S. (2015) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.2015.0954 · Cited by 748
Self-citation
Diets that differ in their FODMAP content alter the colonic luminal microenvironment
Halmos, E. P., Christophersen, C. T., Bird, A. R., Shepherd, S. J., Gibson, P. R., & Muir, J. G. (2015) · Gut · doi:10.1136/gutjnl-2014-307264 · Cited by 681
Self-citation
Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial
Böhn, L., Störsrud, S., Liljebo, T. M., Collin, L., Lindfors, P., Törnblom, H., & Simrén, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.054 · Cited by 628
Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome
Staudacher, H. M., Lomer, M. C. E., Anderson, J. L., Barrett, J. S., Muir, J. G., Irving, P. M., & Whelan, K. (2012) · The Journal of Nutrition · doi:10.3945/jn.112.159285 · Cited by 590
Self-citation
Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome
Ong, D. K., Mitchell, S. B., Barrett, J. S., Shepherd, S. J., Irving, P. M., Biesiekierski, J. R., Smith, S., Gibson, P. R., & Muir, J. G. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06370.x · Cited by 583
Self-citation
Dietary Triggers of Abdominal Symptoms in Patients With Irritable Bowel Syndrome: Randomized Placebo-Controlled Evidence
Shepherd, S. J., Parker, F. C., Muir, J. G., & Gibson, P. R. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.058 · Cited by 549
Self-citation

Show all 142 references

Research works printed but not linked: 2

McNamara, 2019, A nursing and allied health-led functional gastrointestinal disorders clinic is well received by patients, highly efficient, cost-effective, and reduces the need for medical intervention, J Gastroenterol Hepatol, 34, 169
Scarlata, 2020, From a dietitian’s perspective, diets for IBS are not one size fits all, Clin Gastroenterol Hepatol, 18543

Sorted by citations

Gut liver brain axis in diseases: the implications for therapeutic interventions
Yan, M., Man, S., Sun, B., Ma, L., Guo, L., Huang, L., & Gao, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01673-4 · Cited by 314
Irritable bowel syndrome and mental health comorbidity — approach to multidisciplinary management
Staudacher, H. M., Black, C. J., Teasdale, S. B., Mikocka‐Walus, A. A., & Keefer, L. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00794-z · Cited by 292
Self-citation
A Rome Working Team Report on Brain-Gut Behavior Therapies for Disorders of Gut-Brain Interaction
Keefer, L., Ballou, S. K., Drossman, D. A., Ringstrom, G., Elsenbruch, S., & Ljótsson, B. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.09.015 · Cited by 213
Self-citation
AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review
Chey, W. D., Hashash, J. G., Manning, L., & Chang, L. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.12.248 · Cited by 166
Self-citation
Dietary management of adults with IBD — the emerging role of dietary therapy
Fitzpatrick, J. A., Melton, S. L., Yao, C. K., Gibson, P. R., & Halmos, E. P. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00619-5 · Cited by 142
Self-citation
Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes
Jacobs, J. P., Lagishetty, V., Hauer, M. C., Labus, J. S., Dong, T. S., Toma, R., Vuyisich, M., Naliboff, B. D., Lackner, J. M., Gupta, A., et al. (2023) · Microbiome · doi:10.1186/s40168-022-01450-5 · Cited by 133
“Reliance of IBS-associated bacteria on this energy source may explain the clinical association of fermentable carbohydrates with IBS symptoms and clinical improvement with the FODMAPS diet, which restricts dietary intake of fermentable oligosaccharides, disaccharides, monosaccharides, and polyols [66].”
Background
Efficacy and Acceptability of Dietary Therapies in Non-Constipated Irritable Bowel Syndrome: A Randomized Trial of Traditional Dietary Advice, the Low FODMAP Diet, and the Gluten-Free Diet
Rej, A., Sanders, D. S., Shaw, C. C., Buckle, R. L., Trott, N., Agrawal, A., & Aziz, I. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.02.045 · Cited by 113
Esophageal Hypervigilance and Symptom-Specific Anxiety in Patients with Eosinophilic Esophagitis
Taft, T., Carlson, D. A., Simons, M. L., Zavala, S., Hirano, I., Gonsalves, N. P., & Pandolfino, J. E. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.06.023 · Cited by 101
The Role of the FODMAP Diet in IBS
Bertin, L., Zanconato, M., Crepaldi, M., Marasco, G., Cremon, C., Barbara, G., Barberio, B., Zingone, F., & Savarino, E. V. (2024) · Nutrients · doi:10.3390/nu16030370 · Cited by 119
“…to food and frequently modify their diets as a means to enhance their condition, opting for dietary adjustments (e.g., gluten-free diets (GFDs) and elimination diets based on IgG antibody testing) instead of resorting to medications, although their efficacy lacks robust supporting data [24–29].”
Background
Long‐term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome
Staudacher, H. M., Rossi, M., Kaminski, T. W., Dimidi, E., Ralph, F. S. E., Wilson, B., Martin, L. D., Louis, P., Lomer, M. C. E., Irving, P. M., et al. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14241 · Cited by 83
Self-citation
How to Implement the 3-Phase FODMAP Diet Into Gastroenterological Practice
Sultan, N., Varney, J. E., Halmos, E. P., Biesiekierski, J. R., Yao, C. K., Muir, J. G., Gibson, P. R., & Tuck, C. J. (2022) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm22035 · Cited by 77
“Taking an integrated approach through utilizing a range of treatments has recently become the preferred option due to lack of ability to predict response in the individual.(9) In this review paper, we analyze recent literature from search databases including Medline, CINAHL, PubMed and Scopus, to discuss how to implem…”
MethodSelf-citation
Dietary Interventions in Inflammatory Bowel Disease
Godala, M. M., Gaszyńska, E., Zatorski, H., & Małecka-Wojciesko, E. (2022) · Nutrients · doi:10.3390/nu14204261 · Cited by 82
“showed improvement in most IBD-related symptoms such as abdominal pain, bloating and diarrhea in relation to a low FODMAP diet in 72% of patients with CD and 78% of patients with UC without active inflammation [92].”
Background
Food Avoidance and Restriction in Irritable Bowel Syndrome: Relevance for Symptoms, Quality of Life and Nutrient Intake
Melchior, C., Algera, J. P., Colomier, E., Törnblom, H., Simrén, M., & Störsrud, S. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.07.004 · Cited by 75
Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome
Goodoory, V. C., Mikocka‐Walus, A. A., Yiannakou, Y., Houghton, L. A., Black, C. J., & Ford, A. C. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001247 · Cited by 68
Fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial
Nordin, E., Brunius, C. F., Landberg, R., & Hellström, P. M. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab337 · Cited by 65
Long-Term Outcome of Multidisciplinary Versus Standard Gastroenterologist Care for Functional Gastrointestinal Disorders: A Randomized Trial
Basnayake, C., Kamm, M. A., Stanley, A., Wilson-O'Brien, A. L., Burrell, K., Lees-Trinca, I., Khera, A. J., Kantidakis, J., Wong, O., Fox, K., et al. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.12.005 · Cited by 63
Hypermobile Ehlers–Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know
Thwaites, P. A., Gibson, P. R., & Burgell, R. E. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15927 · Cited by 59
Self-citation
Of bowels, brain and behavior: A role for the gut microbiota in psychiatric comorbidities in irritable bowel syndrome
Wilmes, L., Collins, J. M., O’Riordan, K. J., O’Mahony, S. M., Cryan, J. F., & Clarke, G. A. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14095 · Cited by 52
Successful Distancing: Telemedicine in Gastroenterology and Hepatology During the COVID-19 Pandemic
Perisetti, A., & Goyal, H. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-06874-x · Cited by 48
The Intersection of Disorders of Gut-Brain Interaction With Avoidant/Restrictive Food Intake Disorder
Weeks, I., Abber, S. R., Thomas, J. J., Calabrese, S., Kuo, B., Staller, K. D., & Murray, H. B. (2023) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001853 · Cited by 48
Development and Current State of Digital Therapeutics for Irritable Bowel Syndrome
Brenner, D. M., Kassebaum-Ladewski, A., & Kinsinger, S. W. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.09.013 · Cited by 45
Intestinal Permeability in Disorders of Gut–Brain Interaction: From Bench to Bedside
Grover, M., Vanuytsel, T., & Chang, L. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.08.033 · Cited by 43
History of trying exclusion diets and association with avoidant/restrictive food intake disorder in neurogastroenterology patients: A retrospective chart review
Atkins, M., Zar‐Kessler, C., Madva, E. N., Staller, K. D., Eddy, K. T., Thomas, J. J., Kuo, B., & Murray, H. B. (2023) · Neurogastroenterology & Motility · doi:10.1111/nmo.14513 · Cited by 39
Understanding racial disparities in the care of patients with irritable bowel syndrome: The need for a unified approach
Sasegbon, A., & Vasant, D. H. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14152 · Cited by 39
Psychological Considerations in the Dietary Management of Patients With DGBI
Murray, H. B., Doerfler, B., Harer, K. N., & Keefer, L. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001766 · Cited by 37
“INTRODUCTION Dietary interventions for themanagement of symptoms associated with disorders of gut-brain interaction (DGBI) are increasingly prescribed as part of integrated care (1), with varying levels of evidence or scientific premise (see review in this edition) (2).”
BackgroundSelf-citation
Dietary management of irritable bowel syndrome: considerations, challenges, and solutions
Whelan, K., Ford, A. C., Murray, H. B., & Staudacher, H. M. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(24)00238-3 · Cited by 36
Self-citation
A Randomized Parallel-group Study of Digital Gut-directed Hypnotherapy vs Muscle Relaxation for Irritable Bowel Syndrome
Berry, S. K., Berry, R., Recker, D., Botbyl, J., Pun, L., & Chey, W. D. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.06.015 · Cited by 32
Self-citation
The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: Results from the Rome foundation global epidemiology study
Jaafari, H., Houghton, L. A., West, R. M., Agrawal, A., Aziz, I., Black, C. J., Corsetti, M., Shuweihdi, F., Eugenicos, M. P., Paine, P., et al. (2023) · Neurogastroenterology & Motility · doi:10.1111/nmo.14574 · Cited by 31
Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome
Wilson, B., Kanno, T., Slater, R., Rossi, M., Irving, P. M., Lomer, M. C. E., Probert, C. S., Mason, A. J., & Whelan, K. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17609 · Cited by 31
Self-citation
Review article: exclude or expose? The paradox of conceptually opposite treatments for irritable bowel syndrome
Biesiekierski, J. R., Manning, L. P., Murray, H. B., Vlaeyen, J. W. S., Ljótsson, B., & Oudenhove, L. V. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17111 · Cited by 28
Smartphone app‐delivered gut‐directed hypnotherapy improves symptoms of self‐reported irritable bowel syndrome: A retrospective evaluation
Peters, S., Gibson, P. R., & Halmos, E. P. (2023) · Neurogastroenterology & Motility · doi:10.1111/nmo.14533 · Cited by 31
Self-citation
Diet as a therapeutic tool in chronic gastrointestinal disorders: Lessons from the FODMAP journey
Gibson, P. R., Halmos, E. P., So, D., Yao, C. K., Varney, J. E., & Muir, J. G. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15772 · Cited by 59
Self-citation
Associations Between Brain Morphology, Inflammatory Markers, and Symptoms of Fatigue, Depression, or Anxiety in Active and Remitted Crohn’s Disease
Thomann, A., Schmitgen, M. M., Stephan, J. C., Ebert, M. P., Thomann, P. A., Szabo, K., Reindl, W., & Wolf, R. C. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae078 · Cited by 25
Studies on irritable bowel syndrome associated with anxiety or depression in the last 20 years: A bibliometric analysis
Chen, Y., Lian, B., Li, P., Yao, S., & Hou, Z. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.947097 · Cited by 25
Effectiveness of a novel diet in attenuation of clinical activity of disease in patients with ulcerative colitis: a randomized, clinical trial
Narimani, B., Sadeghi, A., Daryani, N. E., Shahrokh, S., Nilghaz, M., Ghods, M., Shafiee, M., Shahparvari, M. R., & Hekmatdoost, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-64512-8 · Cited by 27
Rome Foundation Working Team Report on overlap in disorders of gut–brain interaction
Barbara, G., Aziz, I., Ballou, S., Chang, L., Ford, A. C., Fukudo, S., Nurko, S., Olano, C., Saps, M., Sayuk, G. S., et al. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-01033-9 · Cited by 30
“Most likely, a multidisciplinary and/or multidimensional treatment approach is needed in patients with overlapping DGBI, in particular if simultaneous overlap with non-gastrointestinal conditions is also present 128–130 .”
Gluten and fructan intake and their associations with gastrointestinal symptoms in irritable bowel syndrome: A food diary study
Algera, J. P., Störsrud, S., Lindström, A., Simrén, M., & Törnblom, H. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.09.002 · Cited by 23
Modest Conformity Between Self-Reporting of Bristol Stool Form and Fecal Consistency Measured by Stool Water Content in Irritable Bowel Syndrome and a FODMAP and Gluten Trial
Nordin, E., Hellström, P. M., Brunius, C. F., & Landberg, R. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001942 · Cited by 22
“Dietary adaptations are included in an integrated care model for treatment of IBS (10).”
Background
Efficacy and safety of fecal microbiota transplant in irritable bowel syndrome: An update based on meta‐analysis of randomized control trials
Abdelghafar, Y. A., AbdelQadir, Y. H., Motawea, K. R., Nasr, S. A., Omran, H. A. M., Belal, M. M., Elhashash, M. M., AbdelAzim, A. A., & Shah, J. (2022) · Health Science Reports · doi:10.1002/hsr2.814 · Cited by 21
“The three main pillars for management are medications, dietary plans, and behavioral therapy.(45) There is a reciprocal relationship between brain and gut mediated by hormones, CNS, and PNS.”
Background
The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID‐19 pandemic
Noble, H., Hasan, S. S., Whorwell, P. J., & Vasant, D. H. (2022) · Neurogastroenterology & Motility · doi:10.1111/nmo.14347 · Cited by 21
Role of stress and early-life stress in the pathogeny of inflammatory bowel disease
Bonaz, B. L., Sinniger, V., & Sonia Pellissier, A. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1458918 · Cited by 23
“This can create an allostatic overload and a state of vulnerability (hyper or hyposensitivity; low grade tissue inﬂammation) favoring later development of chronic diseases with pain and inﬂammation such as IBS and IBD.”
BackgroundInfluential
Orthorexia Nervosa Is a Concern in Gastroenterology: A Scoping Review
Tuck, C. J., Sultan, N., Tonkovic, M., & Biesiekierski, J. R. (2022) · Neurogastroenterology & Motility · doi:10.1111/nmo.14427 · Cited by 19
A Review of Pharmacologic and Non-Pharmacologic Therapies in the Management of Irritable Bowel Syndrome: Current Recommendations and Evidence
Papale, A., Flattau, R., Vithlani, N., Mahajan, D., & Nadella, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13226948 · Cited by 21
Treating disorders of brain–gut interaction with multidisciplinary integrated care. Moving towards a new standard of care
Burgell, R., Hoey, L., Norton, K., & Fitzpatrick, J. A. (2024) · JGH Open · doi:10.1002/jgh3.13072 · Cited by 23
“…cohort, a study of 124 patients with refractory GI symptoms and suspected psycho-social contributors found improvement in psychological metrics (Hospital anxiety and depression scale, Short-form 36, and State and trait anxiety inventory) and GI symptoms at 6 months after the combined consultations.”
BackgroundInfluential
Behavioral Strategies for Irritable Bowel Syndrome
Jagielski, C. H., & Riehl, M. E. (2021) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2021.03.006 · Cited by 18
Utilization of Dietitians in the Management of Irritable Bowel Syndrome by Members of the American College of Gastroenterology
Scarlata, K., Eswaran, S., Baker, J. R., & Chey, W. D. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001602 · Cited by 18
“on the 3 phases of the low-FODMAP diet plan (restriction, reintroduction, and personalization), which may unnecessarily overrestrict IBS patients’ diets, potentially increasing the risk of nutritional deficiencies, negatively affecting long-term adherence to the diet plan, and potentially exacerbating disordered eatin…”
BackgroundSelf-citation
Future of Brain–Gut Behavior Therapies: Mediators and Moderators
Burton Murray, H., & Ljótsson, B. (2022) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2022.06.011 · Cited by 17
An Update on the Assessment and Management of Pediatric Abdominal Pain
Friesen, C. A., Colombo, J. M., Deacy, A. D., & Schurman, J. V. (2021) · Pediatric Health Medicine and Therapeutics · doi:10.2147/phmt.s287719 · Cited by 21
The Mediterranean Diet for Irritable Bowel Syndrome
Bamidele, J. O., Brownlow, G., Flack, R. M., Buckle, R. L., Shaw, C. C., Shiha, M. G., & Aziz, I. (2025) · Annals of Internal Medicine · doi:10.7326/annals-25-01519 · Cited by 23
Review of Treatment Options for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation
Patel, S. N., Doerfler, B., Boutros, K., Ng, S., Manuel, M., & DeSimone, E. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s274568 · Cited by 18
The effects of slow deep breathing on microvascular and autonomic function and symptoms in adults with irritable bowel syndrome: A pilot study
Jurek, M. K., Seavey, H. N., Guidry, M. E., Slomka, E. L., & Hunter, S. D. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14275 · Cited by 16
How to Approach a Patient with Difficult-to-Treat IBS
Chang, L. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.07.034 · Cited by 15
Review article: rethinking the “ladder” approach to reflux‐like symptom management in the era of PPI “resistance” ‐ a multidisciplinary perspective
Hungin, A. P. S., Scarpignato, C., Keefer, L., Corsetti, M., Anastasiou, F., Muris, J. W. M., Mendive, J. M., & Kahrilas, P. J. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16930 · Cited by 14
Self-citation
Management of irritable bowel syndrome: a narrative review
Tetali, B., & Suresh, S. (2024) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh-23-96 · Cited by 15
“It is imperative to adopt an integrative model that utilizes a multimodal therapeutic approach to provide optimal care for patients with IBS (54,55).”
Background
Irritable bowel syndrome with food‐related symptoms: Future directions in the clinical management
Melchior, C., Algera, J. P., Colomier, E., Törnblom, H., & Simrén, M. (2022) · United European Gastroenterology Journal · doi:10.1002/ueg2.12265 · Cited by 14
“behavioural interventions are targeting the predominant symptoms and are all considered as equal partners.(20) These treatment strategies should be discussed with the appropriate healthcare professional, that is, gastroenterologist, certified dietician, psychiatrist,”
Background
Role of Nutrition in Gastroesophageal Reflux, Irritable Bowel Syndrome, Celiac Disease, and Inflammatory Bowel Disease
Ahuja, A., Pelton, M., Raval, S. V., & Kesavarapu, K. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.06.010 · Cited by 16
Irritable bowel syndrome and diet
Weber, H. C. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000720 · Cited by 15
Evaluating the content and quality of irritable bowel syndrome videos on social media platforms in China: Focus on TikTok and Bilibili
Xi, W., Feng, R., Li, J., Bai, X., Zhang, Y., Jiang, Q., & Yang, A. (2025) · Digital Health · doi:10.1177/20552076251382029 · Cited by 13
The Pervasive Impact of the Stigmatization of Gastrointestinal Diseases—A Patient’s Perspective
Ruddy, J., & Taft, T. (2022) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2022.06.010 · Cited by 13
Biopsychosocial Aspects of Adult and Pediatric Disorders of Gut–Brain Interaction
Elsenbruch, S., Ballou, S., Keefer, L., Murphy, T., Oudenhove, L. V., van Tilburg, M. A. L., Vasant, D. H., & Levy, R. L. (2026) · Gastroenterology · doi:10.1053/j.gastro.2026.02.009 · Cited by 18
Self-citation
Association between dietary factors, symptoms, and psychological factors in adults with dyspepsia: A cross‐sectional study
Cooke, Z., Resciniti, S. M., Wright, B. J., Hale, M. W., Yao, C. K., Tuck, C. J., & Biesiekierski, J. R. (2023) · Neurogastroenterology & Motility · doi:10.1111/nmo.14684 · Cited by 12
Experience and clinical efficacy of gut‐directed hypnotherapy in an Asian population with refractory irritable bowel syndrome
Sasegbon, A., Hasan, S. S., Whorwell, P. J., & Vasant, D. H. (2022) · JGH Open · doi:10.1002/jgh3.12770 · Cited by 14
Potential of natural products in the treatment of irritable bowel syndrome
Lü, Q., Tan, D., Luo, J., Ye, Y., Zuo, M., Wang, S., & Li, C. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154419 · Cited by 12
Irritable bowel syndrome in midlife women: a narrative review
Yang, P.-L., Heitkemper, M. M., & Kamp, K. (2021) · Women s Midlife Health · doi:10.1186/s40695-021-00064-5 · Cited by 15
“A low FODMAP diet involves removing high FODMAP foods from the diet for 2–6 weeks (restriction), gradually reintroducing foods while monitoring symptoms (reintroduction) and developing a personalized plan (individualization) [100].”
Background
Understanding Disordered Eating Risks in Patients with Gastrointestinal Conditions
Riehl, M. E., & Scarlata, K. (2021) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2021.03.001 · Cited by 16
Systematic Review: Integrated Models of Care for Managing Irritable Bowel Syndrome
Warner, M. M., Soliman, O. M., Crichton, M., Marshall, S., Staudacher, H. M., & Kelly, J. T. (2025) · Neurogastroenterology & Motility · doi:10.1111/nmo.14989 · Cited by 9
“Some integrated models of care offered patients both psychological and dietary therapy, which is considered the minimum for gold standard integrated care [46] and may be particularly relevant given that IBS often co-occurs with mental health conditions [47, 48].”
GutGPT: A multidimensional knowledge-enhanced large language model for gastrointestinal medicine
Zhang, R.-Y., Qiang, P.-P., Hao, Y.-X., Tan, H., Zhao, K., Cai, L.-J., & Wang, J. (2025) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2025.104885 · Cited by 9
Integrated Care for Irritable Bowel Syndrome
Berry, S. K., & Chey, W. D. (2021) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2021.04.006 · Cited by 9
Self-citation
Delivery Methods of Cognitive Behavior Therapy for Patients With Irritable Bowel Syndrome
Chen, L. J., Kamp, K., Fang, A., & Heitkemper, M. M. (2022) · Gastroenterology Nursing · doi:10.1097/sga.0000000000000671 · Cited by 8
Innovative concepts in diet therapies in disorders of gut–brain interaction
So, D., & Tuck, C. J. (2024) · JGH Open · doi:10.1002/jgh3.70001 · Cited by 8
Exploration of differential responses to FODMAPs and gluten in people with irritable bowel syndrome- a double-blind randomized cross-over challenge study
Nordin, E., Landberg, R., Hellström, P. M., & Brunius, C. F. (2024) · Metabolomics · doi:10.1007/s11306-023-02083-x · Cited by 8
“Diet is considered a main cause of symptoms in IBS (Chey et al., 2021).”
A diet low in fermentable oligo‐, di‐, monosaccharides and polyols improves abdominal and overall symptoms in persons with all subtypes of irritable bowel syndrome
Dean, G. D., Chey, S. W., Singh, P. P., & Chey, W. D. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14845 · Cited by 8
“8,9 Despite many randomized controlled trials of a LFD in IBS, there is scant data examining the comparative effectiveness of a LFD in IBS subtypes, particularly IBS-C.”
Self-citation
Integrated care for disorders of gut–brain interaction
Chey, W. D. (2020) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(20)30235-1 · Cited by 7
Self-citation
Group education by dietitians in patients with gastrointestinal disorders: Potentially clinically effective and time for randomised trials
Whelan, K. (2022) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.13010 · Cited by 7
“Gastrointestinal symptoms are commonly related to ingestion of meals or indeed specific foods (3) and over recent years numerous dietary approaches have been investigated that have placed the dietitian as a central component of the team managing IBS (4).”
BackgroundSelf-citation
In Vitro Efficacy of Targeted Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Enzymatic Digestion in a High-Fidelity Simulated Gastrointestinal Environment
Ochoa, K. J. C., Samant, S., Liu, A., Duysburgh, C., Marzorati, M., Singh, P., Hachuel, D., Chey, W. D., & Wallach, T. E. (2022) · Gastro Hep Advances · doi:10.1016/j.gastha.2022.10.011 · Cited by 7
“4,5,9,10,17 However, the low FODMAP diet has several limitations including being time consuming, restrictive, and cumbersome.”
BackgroundSelf-citation
Biscuits for the gut: A symphony of FODMAPs and dietary fibre in gut microbiome for irritable bowel syndrome (IBS) management
Koç, F., Atzler, J. J., Sahin, A. W., Arendt, E. K., Ross, R. P., & Stanton, C. (2024) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2024.103832 · Cited by 7
Symptom bothersomeness and life interference support Rome clinical criteria as clinically relevant indicators of DGBI
Biurra, Y. C., Naude, C., Marchese, S. H., Evans, S., Barber, E., Parigi, E., Cheah, S., Palsson, O. S., Sperber, A. D., Tack, J. F., et al. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14936 · Cited by 7
“31 Importantly, participants noted doctors should provide tangible solutions if they ask about bothersomeness and life interference with specific interventions or lifestyle changes that consider the patient's treatment history, psychological stress, IBS profile, and personal preferences.”
The FODMAP diet: more than just a symptomatic therapy?
Gibson, P. R., & Halmos, E. P. (2021) · Gut · doi:10.1136/gutjnl-2021-326284 · Cited by 6
Self-citation
Practical Approaches to Working with a Gastrointestinal Psychologist
Kinsinger, S. W. (2022) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2022.07.002 · Cited by 5
Avoidant/Restrictive Eating in People With and Without Bowel Symptoms in the General Population: Prevalence, Clinical Profile, and Associated Factors
Blomsten, A., Trindade, I. A., Nybacka, S., Melchior, C., Algera, J. P., Weznaver, C. D., Störsrud, S., Törnblom, H., & Simrén, M. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003735 · Cited by 6
Effective Communication Strategies and Tools for Improving Treatment Outcomes in Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation
Kassebaum-Ladewski, A., Poppers, D. M., & Brenner, D. M. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001686 · Cited by 4
“Treatment for these disorders generally progresses from dietary and lifestyle interventions to pharmacological and/or behavioral therapy in a stepwise or complementary manner (3,4,6,34).”
Background
Internet hospital response to the COVID-19 pandemic in a tertiary hospital in China: Perspectives based on a mixed-methods
Wu, X., Kuang, Y., Guo, Y., Wu, J., & Xiao, L. (2024) · Digital Health · doi:10.1177/20552076241228418 · Cited by 4
“43 – 46 For diagnostic effectiveness in gastroenterology in terms of the distribution of diagnostic symptoms, the main clinical diagnostic symptoms in new patients seen through the Internet medical platform and face-to-face consultations were abdominal pain and constipation/diarrhea, which…”
Background
Engagement in GI Behavioral Health Is Associated with Reduced Portal Messages, Phone Calls, and ED Visits
Arizmendi, B. J., Craven, M. R. A., Martínez‐Camblor, P., Tormey, L. K., & Salwen‐Deremer, J. K. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08428-3 · Cited by 4
“As such, the model of integrated behavioral health care in gastroenterology (GI) practices is increasingly recognized as a standard of care rather than an exception [17, 18].”
The Role of Food in Disorders of Gut-Brain Interaction: Introduction to a Rome Foundation Working Group Series
Chey, W. D., & Tack, J. F. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001744 · Cited by 4
Self-citation
Behavioral Health Digital Therapeutics for Patients With Irritable Bowel Syndrome: A Primer for Gastroenterologists
Saleh, Z. M., Chey, W. D., & Berry, S. K. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002220 · Cited by 4
Self-citation
FODMAPs—Do they really affect IBS symptoms?
Nordin, E., Brunius, C. F., Landberg, R., & Hellström, P. M. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1123576 · Cited by 4
“IBS symptoms are clearly related to other factors beyond diet, such as psychological factors (4).”
BackgroundInfluential
Limited Access to Integral Care: Digital Therapeutics Show Promise of Scalable Solutions to Behavioral Interventions
Riehl, M. E. (2022) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000444 · Cited by 4
Modern aspects of the management of patients with irritable bowel syndrome
Tsukanov, V. V., Vasyutin, A. V., & Tonkikh, Y. L. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-5-22-28 · Cited by 5
First Real‐World Evidence of an AI‐Enhanced Digital Collaborative Care Model to Improve IBS Symptoms
Lupe, S. E., Olson, J. M., Kamp, K., Heitkemper, M. M., Pathipati, M. P., Simons, M. L., Brown, J., Jactel, S. N., Regueiro, M. D., Lembo, A. J., et al. (2025) · Neurogastroenterology & Motility · doi:10.1111/nmo.70144 · Cited by 3
“A third potential mechanism behind these results is the inter-play between the challenges of dietary elimination and the skills gained from BGBTs [27].”
Efficacy and Safety of Postbiotics in Irritable Bowel Syndrome: A Systematic Review and Meta‐Analysis
Ayad, M. E., Yu, S., Shennawy, S. E., Mowafy, E. A. A., Sahran, N., Jad, R. E., & Lee, Y. Y. (2026) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70421 · Cited by 3
The multidimensional clinical profile for disorders of gut-brain interaction
Iyengar, P., & Chang, L. (2024) · NeuroGastroLATAM Reviews · doi:10.24875/ngl.23000008 · Cited by 3
Observation of the clinical efficacy of moxa-stick moxibustion in treating diarrhea-predominant irritable bowel syndrome
Ma, J., Li, G., Sun, F., Qi, Q., Wu, L., Zhao, C., Liu, H., Lu, Y., Ma, X., Chen, L., et al. (2025) · Journal of Acupuncture and Tuina Science · doi:10.1007/s11726-025-1490-4 · Cited by 2
Digital and Conventional Behavioral Therapies for Neurogastroenterology and Motility Disorders
Dave, P. N., & Kinsinger, S. W. (2025) · Current Gastroenterology Reports · doi:10.1007/s11894-025-01007-0 · Cited by 2
Safety, tolerability, and preliminary effects of cricket chitin for adults with IBS: a double-blind randomized crossover pilot trial
Vita, A. A., Teo, S., Murphy, C., Khandaker, A. M., Hart, R. A., Mathews, P., Wilson, J. W., Chaparro, J. M., Aquilino, T. M., Dinsmore, I., et al. (2025) · Food & Function · doi:10.1039/d5fo01540e · Cited by 2
Quercetin Ameliorates Comorbid Insomnia in Diarrhea-Predominant Irritable Bowel Syndrome via the PI3K/AKT/NF-κB Signaling Pathway
Liu, G., Kong, X., Zhao, Y., Cai, N., Wang, H., Sun, H., & Zhao, P. (2026) · Biomedicines · doi:10.3390/biomedicines14030692 · Cited by 2
“Current pharmacotherapies for insomnia and IBS focus mainly on symptom management, targeting neurotransmission, gastrointestinal motility, or sleep–wake regulation, but they provide only transient relief, with fewer than half of patients achieving sustained improvement [6,7].”
Integrative chronic pain management: a narrative review
Halma, M. T. J., Marik, P. E., Saleeby, Y. M., & Tuszyński, J. A. (2025) · Journal of Multiscale Neuroscience · doi:10.56280/1702545951 · Cited by 1
Gastrointestinal effects of diets low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols
Quigley, E. M. M. (2022) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000841 · Cited by 2
FODMAPs or gluten as inducers of symptoms in irritable bowel syndrome: separating the wheat from the chaff
Whelan, K. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab381 · Cited by 2
Self-citation
Editorial: definition of factors associated with poor quality of life in patients with IBS —but where to from here?
Thwaites, P. A., & Burgell, R. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17391 · Cited by 2
Recomendaciones de buena práctica clínica para el uso de neuromoduladores en gastroenterología: revisión conjunta de expertos de la Asociación Mexicana de Gastroenterología (AMG) y Asociación Mexicana de Neurogastroenterología y Motilidad (AMNM)
Gomez-Escudero, O., Remes-Troche, J. M., Coss-Adame, E., García‐Zermeño, K. R., Aquino-Matus, J. E., Pavón, J. J., Valdovinos-García, L. R., Vargas-Martínez, M. A., Amieva‐Balmori, M., Arenas-Martinez, J. S., et al. (2025) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2024.12.001 · Cited by 4

Authors: Chey, W. D., Keefer, L., Whelan, K., & Gibson, P. R.
Affiliations: University of Michigan (US)
King's College London (GB)
Monash University (AU)
Corresponding author: Chey, William D.
ORCID: Chey, William D.
Keefer, Laurie
Whelan, Kevin
Gibson, Peter R.
Venue: Gastroenterology
Publisher: Elsevier BV
Published: 2021-01
Volume: 160
Issue: 1
Pages: 47-62
ISSN: 0016-5085 (ISSN-L)
DOI: 10.1053/j.gastro.2020.06.099
OpenAlex: W3093338182
Cited by: 154
References: 142
Citations by year: 2026: 29 · 2025: 21 · 2024: 22 · 2023: 20 · 2022: 35 · 2021: 25
FWCI: 3.52
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Gastroenterology (publishedVersion)
PubMed (publishedVersion)
Funders: Almond Board of California
Meso Scale Diagnostics
International Nut and Dried Fruit Council
Takeda Pharmaceuticals U.S.A.
Pfizer
Allergan
Topics: Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords: irritable bowel syndrome, behavior therapy, dietary therapy, gut-directed hypnotherapy, cognitive behavioral therapy, FODMAP diet, integrated care, symptom perception, stress, personalized nutrition
MeSH terms: Behavior Therapy, Humans, Delivery of Health Care, Integrated, Irritable Bowel Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Behavioral and Diet Therapies in Integrated Care for Patients With Irritable Bowel Syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks